1-6 of 6
the FRALLE Group
Close
Sort by
Journal Articles

Two Decades of Progresses in Adolescents with Acute Lymphoblastic Leukemia (ALL) Treated in the FRALLE Protocols: Adolescence Is No More a Bad Prognostic Feature If an Intensive Chemotherapy Is Applied.

Andre Baruchel, MD, Marie-Françoise Auclerc, MD, Yves Perel, MD, Françoise Mechinaud, MD, Anne Auvrignon, MD, Claudine Schmitt, MD, Christophe Piguet, MD, Odile Lejars, MD, Christian Berthou, MD, François Demeocq, MD, Pascale Schneider, MD, Virginie Gandemer, MD, Gérard Michel, MD, Jean-Michel Cayuela, Pharm D, Thierry Leblanc, MD, Guy Leverger, MD, the FRALLE Group
Journal: Blood
Blood (2006) 108 (11): 1852.
https://doi.org/10.1182/blood.V108.11.1852.1852
Published: 2006
Journal Articles

A Plateau after 30 Months of Follow-Up in B -Lineage Childhood Acute Lymphoblastic Leukemia (ALL) with t(1;19)(q23;p13)/E2A-PBX1?.

André Baruchel, MD, Sylvie Chevret, MD, PhD, Anne Auvrignon, MD, Paola Ballerini, MD, PhD, Gérard Michel, MD, Jean Gabert, MD, PhD, Christiane Vermylen, MD, Yves Perel, MD, Chrystèle Bilhou-Nabera, MD, Odile Lejars, MD, Claudine Schmitt, MD, Pierre Jonveaux, MD, PhD, Jean Soulier, MD, PhD, Jacqueline Vandenaker, MD, Marie-Françoise Auclerc, MD, Thierry Leblanc, MD, Guy Leverger, MD, for the FRALLE Group
Journal: Blood
Blood (2005) 106 (11): 1441.
https://doi.org/10.1182/blood.V106.11.1441.1441
Published: 2005
Journal Articles

Childhood Standard-Risk B-Cell Precursor Acute Lymphoblastic Leukemia (SR-BCP-ALL): Toxicity and Efficacy Interim Results of the FRALLE 2000-A Protocol.

Andre Baruchel, Anne Auvrignon, Marie-Françoise Auclerc, Yves Perel, Françoise Mechinaud, Virginie Gandemer, Claudine Schmitt, Geneviève Marguerite, Pascale Schneider, Gérard Michel, Christiane Vermylen, Odile Lejars, Christian Berthou, Claire Berger, Catherine Paillard, Gérard Couillault, Brigitte Pautard, Xavier Rialland, Thierry Leblanc, Guy Leverger, the FRALLE group
Journal: Blood
Blood (2004) 104 (11): 1952.
https://doi.org/10.1182/blood.V104.11.1952.1952
Published: 2004
Journal Articles

Intermediate Dose Methotrexate in Low-Risk Acute Lymphoblastic Leukemia. Results of the FRALLE 93A Protocol.

Yves Perel, Hervé Chambost, Virginie Gandemer, Thierry Leblanc, Schneider Pascale, Schmitt Claudine, Mariane Debré, Christiane Vermylen, Gérard Couillault, Jean-Paul Lamagnere, Marie-Françoise Auclerd, Guy Leverger, André Baruchel, the FRALLE group
Journal: Blood
Blood (2004) 104 (11): 1949.
https://doi.org/10.1182/blood.V104.11.1949.1949
Published: 2004
Journal Articles

Minimal Residual Disease (MRD) at the End of Induction (EOI) after a Three or Four-Drug Induction Regimen for Childhood Standard-Risk B-Cell Precursor Acute Lymphoblastic Leukemia (SR-BCP-ALL): Interim Results of the FRALLE 2000-A Protocol.

Jean-Michel Cayuela, Kheira Beljord, Claude Preudhomme, Helene Cavé, Jean-François Eliahou, Marie-Françoise Auclerc, Judith Landman-Parker, Thierry Leblanc, Yves Perel, Françoise Mechinaud, Geneviève Marguerite, Claudine Schmitt, Gérard Michel, Christiane Vermylen, Virginie Gandemer, Sylvie Chevret, Guy Leverger, Elisabeth Macintyre, André Baruchel, the FRALLE Group
Journal: Blood
Blood (2004) 104 (11): 1105.
https://doi.org/10.1182/blood.V104.11.1105.1105
Published: 2004
Journal Articles

Evaluation of Minimal Residual Disease (MRD) by Quantification of TEL-AML1 Transcripts Is a Powerful Prognostic Tool in Children with T(12;21) Positive Acute Lymphoblastic Leukemia (ALL).

Jean-Michel Cayuela, PhD, Paola Ballerini, PhD, Marina Romeo, PhD, Vahid Asnafi, PhD, Marie-Francoise Auclerc, MD, Xavier Fund, PhD, Eric Delabesse, PhD, Christian Bastard, PhD, Jean Gabert, PhD, Jean-Pierre Vanier, MD, Odile Lejars, MD, Mariane Debre, MD, Brigitte Pautard, MD, Gerard Michel, MD, Thierry Leblanc, MD, Guy Leverger, MD, Sylvie Chevret, PhD, Elisabeth Macintyre, PhD, Andre Baruchel, MD, for the FRALLE group
Journal: Blood
Blood (2004) 104 (11): 322.
https://doi.org/10.1182/blood.V104.11.322.322
Published: 2004